PortfoliosLab logo
UL vs. PFE
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between UL and PFE is 0.42, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Performance

UL vs. PFE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in The Unilever Group (UL) and Pfizer Inc. (PFE). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

UL:

1.00

PFE:

-0.50

Sortino Ratio

UL:

1.57

PFE:

-0.54

Omega Ratio

UL:

1.22

PFE:

0.94

Calmar Ratio

UL:

1.29

PFE:

-0.20

Martin Ratio

UL:

2.74

PFE:

-0.86

Ulcer Index

UL:

7.48%

PFE:

13.36%

Daily Std Dev

UL:

18.80%

PFE:

24.13%

Max Drawdown

UL:

-53.55%

PFE:

-58.96%

Current Drawdown

UL:

-6.10%

PFE:

-55.27%

Fundamentals

Market Cap

UL:

$153.47B

PFE:

$126.67B

EPS

UL:

$2.59

PFE:

$1.38

PE Ratio

UL:

24.13

PFE:

16.14

PEG Ratio

UL:

3.03

PFE:

0.57

PS Ratio

UL:

2.53

PFE:

2.03

PB Ratio

UL:

6.79

PFE:

1.40

Total Revenue (TTM)

UL:

$60.76B

PFE:

$62.46B

Gross Profit (TTM)

UL:

$60.76B

PFE:

$42.09B

EBITDA (TTM)

UL:

$13.01B

PFE:

$16.71B

Returns By Period

In the year-to-date period, UL achieves a 9.26% return, which is significantly higher than PFE's -9.84% return. Over the past 10 years, UL has outperformed PFE with an annualized return of 6.62%, while PFE has yielded a comparatively lower 0.79% annualized return.


UL

YTD

9.26%

1M

-0.76%

6M

6.39%

1Y

18.61%

5Y*

7.23%

10Y*

6.62%

PFE

YTD

-9.84%

1M

7.40%

6M

-8.84%

1Y

-12.05%

5Y*

-3.76%

10Y*

0.79%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

UL vs. PFE — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

UL
The Risk-Adjusted Performance Rank of UL is 8282
Overall Rank
The Sharpe Ratio Rank of UL is 8383
Sharpe Ratio Rank
The Sortino Ratio Rank of UL is 8080
Sortino Ratio Rank
The Omega Ratio Rank of UL is 8080
Omega Ratio Rank
The Calmar Ratio Rank of UL is 8888
Calmar Ratio Rank
The Martin Ratio Rank of UL is 7777
Martin Ratio Rank

PFE
The Risk-Adjusted Performance Rank of PFE is 2727
Overall Rank
The Sharpe Ratio Rank of PFE is 2323
Sharpe Ratio Rank
The Sortino Ratio Rank of PFE is 2121
Sortino Ratio Rank
The Omega Ratio Rank of PFE is 2323
Omega Ratio Rank
The Calmar Ratio Rank of PFE is 3636
Calmar Ratio Rank
The Martin Ratio Rank of PFE is 2929
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

UL vs. PFE - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for The Unilever Group (UL) and Pfizer Inc. (PFE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current UL Sharpe Ratio is 1.00, which is higher than the PFE Sharpe Ratio of -0.50. The chart below compares the historical Sharpe Ratios of UL and PFE, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Dividends

UL vs. PFE - Dividend Comparison

UL's dividend yield for the trailing twelve months is around 3.05%, less than PFE's 7.36% yield.


TTM20242023202220212020201920182017201620152014
UL
The Unilever Group
3.05%3.29%3.83%3.61%3.77%3.07%3.18%3.49%2.82%3.44%3.06%3.72%
PFE
Pfizer Inc.
7.36%6.33%5.70%3.12%2.64%3.92%3.68%3.12%3.53%3.69%3.47%3.34%

Drawdowns

UL vs. PFE - Drawdown Comparison

The maximum UL drawdown since its inception was -53.55%, smaller than the maximum PFE drawdown of -58.96%. Use the drawdown chart below to compare losses from any high point for UL and PFE. For additional features, visit the drawdowns tool.


Loading data...

Volatility

UL vs. PFE - Volatility Comparison

The current volatility for The Unilever Group (UL) is 6.63%, while Pfizer Inc. (PFE) has a volatility of 8.61%. This indicates that UL experiences smaller price fluctuations and is considered to be less risky than PFE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

UL vs. PFE - Financials Comparison

This section allows you to compare key financial metrics between The Unilever Group and Pfizer Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


10.00B15.00B20.00B25.00B30.00B20212022202320242025
29.64B
13.72B
(UL) Total Revenue
(PFE) Total Revenue
Values in USD except per share items

UL vs. PFE - Profitability Comparison

The chart below illustrates the profitability comparison between The Unilever Group and Pfizer Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

-20.0%0.0%20.0%40.0%60.0%80.0%100.0%20212022202320242025
100.0%
79.3%
(UL) Gross Margin
(PFE) Gross Margin
UL - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, The Unilever Group reported a gross profit of 29.64B and revenue of 29.64B. Therefore, the gross margin over that period was 100.0%.

PFE - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Pfizer Inc. reported a gross profit of 10.87B and revenue of 13.72B. Therefore, the gross margin over that period was 79.3%.

UL - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, The Unilever Group reported an operating income of 3.45B and revenue of 29.64B, resulting in an operating margin of 11.6%.

PFE - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Pfizer Inc. reported an operating income of 2.79B and revenue of 13.72B, resulting in an operating margin of 20.3%.

UL - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, The Unilever Group reported a net income of 2.04B and revenue of 29.64B, resulting in a net margin of 6.9%.

PFE - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Pfizer Inc. reported a net income of 2.97B and revenue of 13.72B, resulting in a net margin of 21.6%.